Welcome to our dedicated page for Cresco Labs news (Ticker: CRLBF), a resource for investors and traders seeking the latest updates and insights on Cresco Labs stock.
Cresco Labs Inc. (CRLBF) generates a steady flow of news related to its cannabis cultivation, production, branded products and Sunnyside retail dispensaries. As a company that emphasizes a CPG approach to national cannabis brands and a customer-focused retail experience, its announcements often highlight new store openings, market entries and updates on financial performance.
Readers of this news feed can expect coverage of dispensary openings and expansions, such as new Sunnyside locations in regulated medical marijuana and adult-use markets. These stories typically describe how each store fits into Cresco Labs’ broader national footprint and its efforts to provide an educational, approachable retail environment for patients and consumers.
The company also issues financial and operating results updates, including quarterly earnings releases that outline revenue, gross profit, net income or loss and non-GAAP metrics like Adjusted EBITDA and Adjusted gross profit. These releases are often paired with information about conference calls and webcasts for investors, as well as references to related filings on SEDAR+ and EDGAR.
Another key category of Cresco Labs news involves capital structure and financing. The company has announced commitments and closings for senior secured term loan refinancings, describing how these transactions affect its debt profile, maturity schedule and financial flexibility.
Policy and regulatory developments also appear in the news flow. Cresco Labs has commented on significant changes in U.S. cannabis regulation, including federal rescheduling actions, and has framed these events in the context of its mission to normalize and professionalize the cannabis industry. For investors and observers, following CRLBF news provides insight into how the company is expanding its brand portfolio, managing its balance sheet and responding to evolving cannabis laws.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Cresco Labs (OTCQX:CRLBF) continues its expansion in Florida with the opening of a new Sunnyside dispensary at 8717 SW 24th St., Miami, enhancing its retail presence to 29 locations statewide and 64 nationwide. The new facility aims to serve the growing patient base in Miami-Dade, the eighth most populous county in the U.S. with nearly 2.7 million residents. The store offers a broad range of cannabis products from Cresco's branded portfolio, including Cresco, One Plant, and Good News. CEO Charlie Bachtell emphasizes the company's commitment to reaching more patients in populous regions. The store operates Monday to Saturday from 9 AM to 8 PM and Sunday from 9 AM to 6 PM, allowing for both in-store and online orders.
Cresco Labs reported annual revenues of $843 million for 2022, marking a 3% year-over-year increase. Excluding exited California operations, adjusted revenues grew 6%. The company achieved a record 61 million branded units sold and 4.6 million retail transactions, up 37% and 15% respectively. Despite a $215 million net loss due to $141 million in impairment charges, Cresco generated positive operating cash flow of $19 million. The fourth quarter saw a revenue decline of 8% year-over-year, with adjusted gross profit at $90 million. Management remains focused on optimizing operations and maintaining leadership in branded cannabis products.
FAQ
What is the current stock price of Cresco Labs (CRLBF)?
What is the market cap of Cresco Labs (CRLBF)?
